Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual
Leah J Homad,
Anna J MacCamy,
K. Rachael Parks,
Nicholas K. Hurlburt,
Madeleine F Jennewein,
Nicholas R. Akins,
Andrew B Stuart,
Rachael E. Nelson,
Kristen W Cohen,
M. Juliana McElrath,
Janet A Englund,
Helen Y. Chu,
Andrew T. McGuire,
Posted 12 May 2020
bioRxiv DOI: 10.1101/2020.05.12.091298
Posted 12 May 2020
B cells specific for the SARS-CoV-2 S envelope glycoprotein spike were isolated from a COVID-19-infected subject using a stabilized spike-derived ectodomain (S2P) twenty-one days post-infection. Forty-four S2P-specific monoclonal antibodies were generated, three of which bound to the receptor binding domain (RBD). The antibodies were minimally mutated from germline and were derived from different B cell lineages. Only two antibodies displayed neutralizing activity against SARS-CoV-2 pseudo-virus. The most potent antibody bound the RBD in a manner that prevented binding to the ACE2 receptor, while the other bound outside the RBD. Our study indicates that the majority of antibodies against the viral envelope spike that were generated during the first weeks of COVID-19 infection are non-neutralizing and target epitopes outside the RBD. Antibodies that disrupt the SARS-CoV-2 spike-ACE2 interaction can potently neutralize the virus without undergoing extensive maturation. Such antibodies have potential preventive/therapeutic potential and can serve as templates for vaccine-design. ### Competing Interest Statement The authors have declared no competing interest.
- Downloaded 2,042 times
- Download rankings, all-time:
- Site-wide: 6,366
- In immunology: 171
- Year to date:
- Site-wide: 23,177
- Since beginning of last month:
- Site-wide: 19,037
Downloads over time
Distribution of downloads per paper, site-wide
- 27 Nov 2020: The website and API now include results pulled from medRxiv as well as bioRxiv.
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!